Caffeic acid phenethyl ester protects nigral dopaminergic neurons via dual mechanisms involving haem oxygenase‐1 and brain‐derived neurotrophic factor
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND PURPOSE: Caffeic acid phenethyl ester (CAPE) is a component of honey bee propolis that can induce expression of haem oxygenase‐1 (HO‐1). Because HO‐1 induction has been suggested to protect dopaminergic neurons in the substantia nigra, we examined the effect of CAPE in experimental models of dopaminergic neurodegeneration. EXPERIMENTAL APPROACH: Neuroprotective effect of CAPE was investigated in rat organotypic midbrain slice cultures and in vivo, using a mouse model of dopaminergic neurodegeneration induced by intranigral injection of LPS and intrastriatal injection of 6‐hydroxydopamine. KEY RESULTS: CAPE protected dopaminergic neurons in slice cultures from IFN‐γ/LPS‐induced injury. The effect of CAPE was inhibited by zinc protoporphyrin IX, an HO‐1 inhibitor, and by neutralizing antibody against brain‐derived neurotrophic factor (BDNF). A p38 MAPK inhibitor SB203580 prevented activation of NF‐E2‐related factor 2, attenuated increased expression of HO‐1 and BDNF, and blocked the neuroprotective actions of CAPE. In the LPS‐injected mouse model, daily intraperitoneal administration of CAPE protected dopaminergic neurons, up‐regulated HO‐1 and BDNF, and reduced the increase of activated microglia/macrophages. Neuroprotective effects of CAPE against LPS‐induced injury was prevented by zinc protoporphyrin IX or anti‐BDNF antibody. CAPE protected dopaminergic neurons and alleviated methamphetamine‐induced rotational behaviour also in 6‐hydroxydopamine hemiparkinsonian mice. CONCLUSION AND IMPLICATIONS: CAPE is a novel type of neuroprotective agent whose actions are mediated by both HO‐1 and BDNF. These findings may provide novel clues to develop neuroprotective agents for treatment of neurodegenerative disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Thomas, B., & Beal, M. F. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm159 · Cited by 748
Greer, P. L., & Greenberg, M. E. (2008) · Neuron · doi:10.1016/j.neuron.2008.09.002 · Cited by 661 · cited 1×
“In contrast, PD98059 did not affect CAPEinduced expression of BDNF, although ERK1/2 regulates BDNF gene expression in several types of cells (Greer and Greenberg, 2008; Kurauchi et al., 2011).”
BackgroundMcGeer, P. L., Schwab, C., Parent, A., & Doudet, D. (2003) · Annals of Neurology · doi:10.1002/ana.10728 · Cited by 400 · cited 1×
“…of Parkinson’s disease still remain poorly understood, the disease pathology is generally associated with inflammatory processes and oxidative stress manifested by activated microglia in SNpc that accelerate and exacerbate neurodegeneration (McGeer et al., 1988; 2003; Hirsch et al., 1998).”
BackgroundArai, H., Furuya, T., Yasuda, T., Miura, M., Mizuno, Y., & Mochizuki, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407328200 · Cited by 122 · cited 1×
“We also examined expression levels of IL-1b, because IL-1b has been suggested to mediate neurotoxic effects of LPS on dopaminergic neurons in vivo (Arai et al., 2004).”
BackgroundNFκB inhibitors induce cell death in glioblastomas
Zanotto-Filho, A., Braganhol, E., Schröder, R., de Souza, L. H. T., Dalmolin, R. J. S., Pasquali, M. A. B., Gelain, D. P., Battastini, A. M. O., & Moreira, J. C. F. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.10.014 · Cited by 117
Cheng, S.-E., Lee, I.-T., Lin, C.-C., Kou, Y. R., & Yang, C.-M. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.02.026 · Cited by 86 · cited 3×
“Because MAPK signalling has been reported to regulate Nrf2 activation in various cell types (Cheng et al., 2010; Jeong et al., 2010), we next examined the effect of specific inhibitors of MAPK signalling pathways on Nrf2 nuclear localization and HO-1 protein expression Figure 1”
Background
Cited by
Vauzour, D. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/914273 · Cited by 424
Barros Silva, R., Santos, N. A. G., Martins, N. M., Ferreira, D. A. S., Barbosa, F., Oliveira Souza, V. C., Kinoshita, Â., Baffa, O., Del-Bel, E., & Santos, A. C. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.12.041 · Cited by 88
Nam, J. H., Leem, E., Jeon, M.-T., Jeong, K. H., Park, J.-W., Jung, U. J., Kholodilov, N., Burke, R. E., Jin, B. K., & Kim, S. R. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8729-2 · Cited by 76
Miyazaki, I., Isooka, N., Wada, K., Kikuoka, R., Kitamura, Y., & Asanuma, M. (2019) · Cells · doi:10.3390/cells8030221 · Cited by 53
“The dosages of CA (30 mg/kg/day) and CGA (50 mg/kg/day) were determined based on previous reports [22,24,25].”
Method
Metadata
- Authors
- Kurauchi, Y., Hisatsune, A., Isohama, Y., Mishima, S., & Katsuki, H.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2012-05-08
- Volume
- 166
- Issue
- 3
- Pages
- 1151-1168
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1480863120
- Cited by
- 83
- References
- 7
- FWCI
- 4.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Caffeic acid phenethyl ester protects nigral dopaminergic neurons via dual mechanisms involving haem oxygenase‐1 and brain‐derived neurotrophic factor. https://app.cochat.ai/papers/10.1111/j.1476-5381.2012.01833.x
- The paper
- Kurauchi, Y., Hisatsune, A., Isohama, Y., Mishima, S., & Katsuki, H. (2012). Caffeic acid phenethyl ester protects nigral dopaminergic neurons via dual mechanisms involving haem oxygenase‐1 and brain‐derived neurotrophic factor. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2012.01833.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.